RCMT
Next earnings: Aug 5, 2026
Signal
Leaning Bullish21
Price
1
Move-20.17%Selling pressure
Volume
1
Volume3.0× avgSurge — unusual activity
Technical
1
RSIRSI 53Momentum positive
PRICE
Prev Close
28.96
Open
26.80
Day Range22.64 – 27.80
22.64
27.80
52W Range17.26 – 32.50
17.26
32.50
38% of range
VOLUME & SIZE
Avg Volume
67.9K
FUNDAMENTALS
P/E Ratio
10.9x
Value territory
EPS (TTM)
Div Yield
No dividend
Beta
1.20
Market-like
Performance
1D
-20.17%
5D
-19.58%
1M
-23.85%
3M
+24.64%
6M
+18.99%
YTD
+13.06%
1Y
+1.23%
Best: 3M (+24.64%)Worst: 1M (-23.85%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +9% YoY
Valuation
CHEAP
P/E 11x vs ~20x sector
Health
STRONG
CR 1.9 · FCF $0.50/sh
Strong Buy
Key MetricsTTM
Market Cap$163.87M
Revenue TTM$317.97M
Net Income TTM$15.99M
Free Cash Flow$3.81M
Gross Margin27.2%
Net Margin5.0%
Operating Margin7.7%
Return on Equity37.8%
Return on Assets11.8%
Debt / Equity0.11
Current Ratio1.92
EPS TTM$2.10
Alpha SignalsFull Analysis →
What Moves This Stock

Engineering segment bookings and project pipeline visibility, particularly in aerospace/defense and commercial infrastructure where multi-quarter engagements drive revenue predictability

Healthcare IT staffing utilization rates and bill rate trends, as hospital system IT budgets fluctuate with reimbursement pressures and EHR implementation cycles

Gross margin trends reflecting ability to maintain bill rate/pay rate spreads amid wage inflation and competition for technical talent

Working capital management and DSO (days sales outstanding), as staffing firms are sensitive to client payment terms and cash conversion cycles

Macro Sensitivity
Economic Cycle

high - Staffing firms are highly cyclical as corporate clients reduce contingent labor during economic slowdowns to preserve cash. Engineering segment tied to capital expenditure cycles in aerospace, infrastructure, and commercial construction (all GDP-sensitive). Healthcare IT segment more defensive but still exposed to hospital system budget pressures during recessions. Industrial production and business confidence directly correlate with demand for technical staffing services.

Interest Rates

Rising rates negatively impact RCMT through multiple channels: (1) clients delay capital projects requiring engineering services as financing costs increase, (2) healthcare systems face higher debt service costs reducing discretionary IT spending, (3) higher discount rates compress valuation multiples for low-growth staffing firms, and (4) working capital financing becomes more expensive given DSO typically 60-75 days. The 0.92x debt/equity ratio creates moderate direct interest expense sensitivity.

Key Risks

Commoditization of mid-tier staffing services as digital platforms and gig economy models disintermediate traditional staffing firms, compressing margins and reducing barriers to entry

Regulatory changes to independent contractor classification (e.g., AB5-style legislation) that increase compliance costs and limit flexible workforce models

Automation and AI reducing demand for certain technical roles, particularly in healthcare documentation and routine engineering tasks

Investor Profile

value - The 0.4x price/sales and 7.0x EV/EBITDA multiples suggest deep value orientation, attracting investors seeking cyclical recovery plays or potential takeout candidates. The 35.6% ROE indicates efficient capital deployment despite modest scale. Declining stock performance (-24.5% over 6 months) and negative earnings growth have likely driven out momentum investors, leaving contrarian value buyers and special situation funds. The $100M market cap limits institutional ownership to microcap specialists.

Watch on Earnings
Industrial Production Index (INDPRO) as leading indicator for engineering services demand from manufacturing and infrastructure clientsNonfarm payrolls and unemployment rate trends signaling overall labor market tightness affecting recruiting costs and talent availabilityFederal funds rate and 10-year Treasury yield impacting client capital expenditure decisions and project financing costsHealthcare system operating margins (via industry reports) indicating budget availability for IT staffing and documentation services
Health Radar
4 strong1 watch1 concern
72/100
Liquidity
1.92Watch
Leverage
0.11Strong
Coverage
9.2xStrong
ROE
37.8%Strong
ROIC
21.7%Strong
Cash
$3MConcern
ANALYST COVERAGE3 analysts
BUY
Buy
267%
Hold
133%
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 53 — Bullish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.92 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 31, 2026
In 106 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 9.4%

-7.9% vs SMA 50 · +0.8% vs SMA 200

Momentum

RSI53.1
Neutral territory
MACD+0.86
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$32.50+40.6%
EMA 50
$26.52+14.7%
EMA 200
$23.92+3.5%
Current
$23.12
52W Low
$17.26-25.3%
52-Week RangeMid-range
$17.2638th %ile$32.50
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:2
Dist days:4
Edge:+2 dist
Volume Context
Avg Vol (50D)74K
Recent Vol (5D)
98K+32%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 1 analyst
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$270.2M
$269.2M$271.2M
$2.13
±0%
Low1
FY2025
$280.5M
$279.5M$281.5M
+3.8%$2.36+11.1%
±0%
Low1
FY2026(current)
$317.4M
$316.2M$318.5M
+13.1%$2.31-1.9%
±0%
Low1
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryRCMT
Last 8Q
-3.4%avg beat
Beat 3 of 8 quartersMissed 5 Estimates rising
-6%
Q3'24
-8%
Q4'24
-34%
Q1'25
+12%
Q2'25
+13%
Q3'25
-7%
Q4'25
+24%
Q2'26
-23%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $1.0M sold · 30d window
Saks MichaelDivision Presi…
$39K
May 4
SELL
Miller Kevin DCFO
$611K
May 4
SELL
Miller Kevin DCFO
$151K
Apr 27
SELL
Miller Kevin DCFO
$47K
Apr 22
SELL
Miller Kevin DCFO
$94K
Apr 24
SELL
Miller Kevin DCFO
$96K
Apr 17
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
RENAISSANCE TECHNOLOGIES LLC
435K
2
BlackRock, Inc.
296K
3
Pacific Ridge Capital Partners, LLC
286K
4
DIMENSIONAL FUND ADVISORS LP
170K
5
Ballast Asset Management, LP
161K
6
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
154K
7
SEI INVESTMENTS CO
127K
8
GEODE CAPITAL MANAGEMENT, LLC
113K
News & Activity

RCMT News

About

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in the delivery of these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America and Serbia.

Bradley S. ViziExecutive Chairman & President
Michael SaksDivision President of Health Care Services
William D. GarganoGroup Senior Vice President of IT & Life Sciences Services
PeersIndustrials(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
RCMT
$23.12-20.17%$164M11.0+1473.7%511.4%1500
$888.31+0.00%$409.2B1526
$281.53-3.43%$294.2B1488
$171.18+0.00%$230.5B1486
$220.49+0.00%$173.8B1502
$270.56+0.45%$160.6B22.2+107.2%2912.3%1506
$399.44+0.00%$155.1B1506
Sector avg-3.31%16.6+790.4%1711.8%1502